Trial intelligence / Profile preview

Effects of methylphenidate, estradiol, and progesterone on performance monitoring and emotion regulation in healthy women

NL-OMON61781Not yet recruiting

Sponsor
Leiden University
Start
Oct 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of methylphenidate, estradiol and progesterone (4 arms), sponsored by Leiden University. Primary endpoints: Error-related negativity, Reward-related positivity and 5 more. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

methylphenidateestradiolprogesterone

Beyond the preview

Go deeper on NL-OMON61781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON61781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call